OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert BNTX.../  DE000ME5FJ19  /

Stuttgart
2024-09-20  4:03:17 PM Chg.+0.21 Bid4:04:07 PM Ask4:04:07 PM Underlying Strike price Expiration date Option type
64.20EUR +0.33% 64.20
Bid Size: 2,500		 64.29
Ask Size: 2,500		 BioNTech SE - USD 2025-06-27 Call
GlobeNewswire 08-29 Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth
TeleTrader 08-22 FDA okays Moderna, Pfizer updated vaccines
GlobeNewswire 08-22 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 08-16 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 08-14 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 08-08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08-08 Genmab Updates 2024 Financial Guidance
TeleTrader 08-05 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 08-05 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08-05 Genmab Takes Full Control of Acasunlimab Development Program
GlobeNewswire 08-01 Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 07-30 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 07-22 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 06-27 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 06-24 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 06-01 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 05-29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 05-21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 05-17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 05-17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 05-09 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 05-06 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 05-06 Europe mixed premarket with data on the limelight